INITIAL CLINICAL-TRIALS WITH A TUBLESS LITHOTRIPTOR

被引：10

作者：

LIPSON, SB ^{[1
]}

ROSS, LS ^{[1
]}

SONDA, LP ^{[1
]}

机构：

[1] UNIV MICHIGAN,DEPT SURG,DIV UROL,ANN ARBOR,MI 48109

来源：

JOURNAL OF UROLOGY | 1990年 / 143卷 / 01期

关键词：

D O I：

10.1016/S0022-5347(17)39849-X

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

The Medstone 1050 is a new tubless lithotriptor developed in the United States. Under Food and Drug Administration guidelines a human treatment protocol has been developed. The first 50 patients treated at a single site and followed for a minimum of 3 months are presented. All stones treated were 3 cm. or less in longest dimension and located in the renal pelvis, calices or proximal ureter. An adequate fragmentation rate of 90% was achieved in this group. There were no significant complications in any patient. A larger multicenter study presently is underway.

引用

页码：10 / 12

页数：3

共 5 条

[1] ESWL - A LOOK FROM DIFFERENT ANGLES [J].